��������

Sonal Bhatia, MD, currently serves as an Executive and Founding Board Member at Blend, where collaboration among visionary enterprise leaders is fostered. With extensive experience at Pfizer since 2007, Sonal Bhatia has held various leadership positions, including CMO and SVP of US Medical Affairs for Rare Disease, Immunology & Inflammation, and Hospital Business. Additionally, Sonal Bhatia is a board member for Pratham USA and the American Heart Association, contributing to the Go Red for Women initiative. Previous experience includes a Vice President role at Cline Davis & Mann. An educational background includes an MD from Ross University School of Medicine, followed by residency programs at the University of Maryland School of Medicine and the Icahn School of Medicine at Mount Sinai. Currently pursuing a Master of Science in Integrative Health & Ayurveda at Maharishi International University, anticipated completion in June 2025, following a Bachelor of Science in Cellular and Molecular Biology from the University of Toronto.